Literature DB >> 21986395

A case of drug-induced hypersensitivity syndrome due to carbamazepine.

Mitsuaki Morimoto1, Yutaka Watanabe, Takehiro Arisaka, Atsushi Takada, Morio Tonogi, Gen-yuki Yamane, Daihei Fukushima, Shin-ichi Takahashi, Yoichi Tanaka.   

Abstract

The patient was a 51-year-old man who had been prescribed carbamazepine for right third-branch trigeminal neuralgia. He had stopped taking the medication after the neuralgia resolved. When the neuralgia recurred, he resumed medication, and about 1 month later he developed fever, fatigue, cervical lymphadenopathy, generalized skin flushing, facial edema and perioral vesicles, and was admitted to Ichikawa General Hospital, Tokyo Dental College. Oral findings showed reddening and erosion of the buccal mucosa. Routine laboratory examination revealed leukocytosis and hepatic dysfunction. Human herpesvirus 6 antibody titer remarkably increased during development of eruptions. These findings led to a diagnosis of drug-induced hypersensitivity syndrome. Carbamazepine was discontinued, and prednisolone (30 mg/day) was started and tapered based on improvement of symptoms. Because skin symptoms recurred after he was discharged 15 days after admission, the dose of prednisolone was increased and the symptoms finally disappeared. The patient has experienced no further recurrence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986395     DOI: 10.2209/tdcpublication.52.135

Source DB:  PubMed          Journal:  Bull Tokyo Dent Coll        ISSN: 0040-8891


  2 in total

Review 1.  Characterizing DRESS syndrome recurrence: a systematic review.

Authors:  Ajay N Sharma; Samantha Shwe; Vignesh Ravi; Melanie Miller; Natasha A Mesinkovska; Nathan W Rojek; Scott Worswick
Journal:  Arch Dermatol Res       Date:  2021-09-10       Impact factor: 3.033

2.  Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case series.

Authors:  Maulin Mehta; Jay Shah; Tejas Khakhkhar; Rima Shah; K G Hemavathi
Journal:  J Pharmacol Pharmacother       Date:  2014-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.